Hypoglycaemia after initiation of treatment with etanercept in a patient with type 2 diabetes mellitus.
Bonilla
E
E
Lee
Y Y
YY
Phillips
P E
PE
Perl
A
A
D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000150:complications / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D000068800:Etanercept; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept